Zealand Seeks to Usurp Wegovy, Zepbound With New Obesity Drug
There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Metro Times2d
What Is the Ideal Semaglutide Dose for Weight Loss?
The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...
Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Everyday Health16d
FDA Approves First Medication for Obstructive Sleep Apnea
In both trials, people taking either dose of Zepbound experienced a significant reduction in the number of apneas and hypopneas per hour, as measured by the apnea-hypopnea index (AHI). Apneas are ...
Daily Mail16d
Elon Musk upgrades to 'King Kong' of weight-loss drugs after taking Ozempic as he shares slimmed-down Santa picture at Christmas
Mounjaro was approved by the Food and Drug Administration to serve as weight management drug in November 2023 under the brand name Zepbound ... start on a 2.5 mg-dose injection once per ...
People17d
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 Charlotte Phillipp is a Weekend Writer-Reporter at ...
People19d
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...
McKnight's Long-Term Care News19d
FDA approves Zepbound for sleep apnea in patients with obesity
(HealthDay News) — The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA). In a news ...
AOL19d
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.
Business Insider19d
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...
Mint19d
Competition will make weight-loss drugs better, cheaper and bigger
Over the past two years rocketing sales of Wegovy and its main rival, Zepbound, have propelled the ... from $15bn this year to $94bn by 2030 (see chart 1). With hundreds of challengers eyeing ...